Treating Chronic Pain, Migraine & Muscle Spasticity Through Inhibition Of Neurotransmitter Glutamate
Jun 30th 2008Drug InformationHeadache / Migraine
A Webinar hosted by TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of the neurotransmitter glutamate. The company’s President and Chief Executive Officer, Neil Kurtz, M.D., will moderate a discussion following brief presentations by: Tony Yaksh, Ph.D.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
